AI/ML in Pharma
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Unlock global pharma market insights with AI/ML innovations. Discover drug discovery, clinical trial optimization, and regulatory intelligence for investors.
Showing 1–8 of 8 articles
Quick answer
NovaPharmaNews AI/ML in Pharma hub for NMPA covers 8 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Drug Discovery Technology Market Size Tops USD 80.27 Billion by 2035
BeOne's 'One Save Changes Everything' Campaign: A New Era in Pharma Marketing
Pfizer AI Strategy: Driving Pharma Innovation and Dominance
AI Drug Discovery Patent Rankings 2025: Deep EigenMatics Leads Globally
AI-Driven Drug Discovery Partnership: Merck and Mayo Clinic Lead Innovation
Pharma Supercomputer: Eli Lilly and NVIDIA’s AI-Powered Breakthrough
Merck Mayo Clinic AI Partnership: Advancing Drug Discovery
Sanyou AI-STAL 2.0 Reduces Antibody Discovery Time from Months to 14 Days in Drug Development Breakthrough
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.